Ming Fan

Union Hospital
Wuhan, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Neoadjuvant chemoimmunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma: a multicenter cohort study.

Neoadjuvant chemoimmunotherapy versus chemoradiotherapy for esophageal squamous cell carcinoma: a multicenter cohort study.

Journal: Frontiers in immunology

Published: May 15, 2026

Dose optimization of sacubitril/valsartan in Chinese chronic heart failure patients: integration of physiologically based pharmacokinetic modeling and real-world data.

Dose optimization of sacubitril/valsartan in Chinese chronic heart failure patients: integration of physiologically based pharmacokinetic modeling and real-world data.

Journal: Frontiers in pharmacology

Published: May 07, 2026

Precision nutrition in critical illness: a phase-specific framework from acute feeding to post-ICU recovery.

Precision nutrition in critical illness: a phase-specific framework from acute feeding to post-ICU recovery.

Journal: Frontiers in nutrition

Published: April 19, 2026

The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies.

The role of Epstein-Barr virus in NK/T cell lymphoproliferative disorders: molecular mechanisms and potential therapeutic strategies.

Journal: Frontiers in immunology

Published: March 09, 2026

Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Efficacy of Jishi Shuanghua Granules in preventing radiation-induced esophagitis in non-small cell lung cancer patients undergoing concurrent chemoradiotherapy: protocol for a multicenter, randomized, double-blind, placebo-controlled trial.

Journal: Frontiers in medicine

Published: February 20, 2026

Modified sini powder for the management of postoperative depression in non-small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial protocol.

Modified sini powder for the management of postoperative depression in non-small cell lung cancer patients: a multicenter, randomized, double-blind, placebo-controlled trial protocol.

Journal: Frontiers in pharmacology

Published: February 06, 2026

Low-dose fractionated radiotherapy combined with induction chemotherapy in high-risk nasopharyngeal carcinoma: An open-label, randomized phase 2 trial.

Low-dose fractionated radiotherapy combined with induction chemotherapy in high-risk nasopharyngeal carcinoma: An open-label, randomized phase 2 trial.

Journal: Oral oncology

Published: January 05, 2026

External validation and updating of NTCP models for radiation pneumonitis: QUANTEC, Appelt, and a local simplified model.

External validation and updating of NTCP models for radiation pneumonitis: QUANTEC, Appelt, and a local simplified model.

Journal: Frontiers in oncology

Published: December 30, 2025

Piperacillin-tazobactam-associated thrombocytopenia with negative antiplatelet antibody testing: a case report and literature review.

Piperacillin-tazobactam-associated thrombocytopenia with negative antiplatelet antibody testing: a case report and literature review.

Journal: Frontiers in medicine

Published: December 25, 2025

Early prediction of parotid glands secretory function based on ADC variations during radiotherapy for nasopharyngeal carcinoma: a phase II prospective study.

Early prediction of parotid glands secretory function based on ADC variations during radiotherapy for nasopharyngeal carcinoma: a phase II prospective study.

Journal: Radiation oncology (London, England)

Published: April 26, 2025

Prognostic value of ultrasound carotid plaque length in patients with coronary artery disease.

Prognostic value of ultrasound carotid plaque length in patients with coronary artery disease.

Journal: Chinese medical journal

Published: September 17, 2024

A prospective, single-arm trial of PD-1 inhibitors plus chemoradiotherapy for solitary metachronous metastasis nasopharyngeal carcinoma.

A prospective, single-arm trial of PD-1 inhibitors plus chemoradiotherapy for solitary metachronous metastasis nasopharyngeal carcinoma.

Journal: Oral oncology

Published: September 30, 2023

Showing 1-12 of 47

Last Updated: 09/26/2026